Table of Content

MARCH 2021 ISSUE
FREE ACCESS: ROUNDTABLE: TKIs Beyond Second-Line Therapy: New Perspectives in Renal Cell Carcinoma Therapeutics
FREE ACCESS: Dissecting the role of lymphadenectomy in the management of renal cell carcinoma
FREE ACCESS: It’s Clear as Day: HIF Signaling is Driving Force of the Clear Cell Morphology
FREE ACCESS: Editor's Memo - Robert A. Figlin, MD
FREE ACCESS: Journal Club
Newsworthy, late-breaking information from Web-based sources, professional societies, and government agencies
FREE ACCESS: Editor's Memo - Robert A. Figlin, MD (Recent)

DECEMBER 2020 ISSUE
FREE ACCESS: Impact of Mycobacterial Infections on Outcomes of Patients with Metastatic Renal Cell Carcinoma
FREE ACCESS: Dissecting the role of lymphadenectomy in the management of renal cell carcinoma
FREE ACCESS: HIF-inhibitors in Renal Cell Carcinomas: A Review of Current Trials
FREE ACCESS: Academic Mentorship: Choosing the Right Research Mentor(s)
KCJ EDITOR’S MEMO
KCJ MEDICAL INTELLIGENCE
KCJ JOURNAL CLUB - ESSENTIAL PEER-REVIEWED READING IN KIDNEY CANCER (FREE ACCESS available soon)

Table of Contents